Area of research
Cardiology and Cardiovascular Medicine · Complementary and alternative medicine
Research interest
Research interests include Medicine, Internal medicine, Ejection fraction, Heart failure, Cardiology, and Cardiorespiratory fitness.
Interleukin-1 Blockade in Heart Failure: An On-Treatment and Off-Treatment Cardiorespiratory Fitness Analysis
Differential Response to Interleukin‐1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction
Interleukin-1 Inhibition for the Prevention and Treatment of Heart Failure
Acute Myocarditis Associated With Desmosomal Gene Variants
Heart Failure After ST-Elevation Myocardial Infarction: Beyond Left Ventricular Adverse Remodeling
Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection Fraction
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The <scp>CANA‐HF</scp> study
Cardiopulmonary exercise testing – refining the clinical perspective by combining assessments
Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer Survivors
Determinants of Cardiorespiratory Fitness in Patients with Heart Failure Across a Wide Range of Ejection Fractions
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction
Low NT-proBNP Levels in Overweight and Obese Patients Do Not Rule Out a Diagnosis of Heart Failure with Preserved Ejection Fraction
Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein
Rationale and design of the Virginia Commonwealth University–Anakinra Remodeling Trial‐3 (VCU‐ART3): A randomized, placebo‐controlled, double‐blinded, multicenter study
C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction
Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure
Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction
Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐<scp>HART2</scp>)
Impaired Myocardial Relaxation with Exercise Determines Peak Aerobic Exercise Capacity in Heart Failure with Preserved Ejection Fraction
Severely Impaired Cardiorespiratory Fitness in Patients With Recently Decompensated Systolic Heart Failure
Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure